The FDA's announcement of a positive cyclospora test in a Taylor Farms lettuce sample, which was subsequently retracted as a false positive, caused internal debate and confusion, particularly given the public health imperative to address a widespread outbreak linked to Taco Bell. The agency, under Acting Commissioner Kyle Diamantas, prioritized publicizing the initial result despite not completing a full quality control review, due to the escalating number of illness cases and the fact that the sample fell outside the scope of Taylor Farms' voluntary recall. This decision aimed to prevent further distribution of potentially contaminated product and inform the public about the risk.
The initial positive test on a border-surveillance sample of Taylor Farms de Mexico product was announced on Saturday, but by Sunday, the FDA issued a correction, stating the finding was a "false positive" after a re-review by laboratory experts. Despite this retraction, the FDA maintained that the epidemiological data and ongoing outbreak investigation linking Taylor Farms to the outbreak remain unchanged. Former FDA Commissioner Scott Gottlieb supported the FDA's stance, emphasizing that the primary evidence for the outbreak investigation was epidemiological, not solely dependent on the retracted lab test.
Taylor Farms, while stating the FDA apologized for the false positive and that no positive product test results for cyclospora have been identified, had already issued a voluntary recall of iceberg lettuce grown and processed in central Mexico on July 17. The company further clarified it would no longer source iceberg lettuce from central Mexico for the remainder of the growing season. The outbreak has affected over 1,600 confirmed cases across multiple states, with Michigan alone reporting 6,148 cases and 102 hospitalizations, primarily linked to Taco Bell restaurants in five states.
The FDA's decision to publicize the initial positive result, even with the subsequent retraction, highlights a balancing act between swift public health warnings during an unfolding crisis and ensuring the accuracy of complex laboratory findings. The agency defended its transparency, emphasizing the public health need to disseminate actionable information as quickly as possible during a rapidly evolving foodborne illness outbreak, which has resulted in thousands of illnesses but no reported deaths.
